PKBDO2463XMPN
PKBDO2463XMPN
released
Clinical summary
Diabetes status
Type 2 Diabetes
Age (y)
61
Age group
40-64
BMI
33.1
Height (cm)
—
Weight (kg)
—
HbA1c %
9
C-Peptide (ng/ml)
—
Diabetes duration
0-5
Demographics
- Age (y)
- 61
- Age group
- 40-64
- Pediatric
- No
- Gender
- Male
- Ethnicity
- African American
Additional clinical
- Diabetes (ontology)
- T1D stage
- No sufficient information to derive
- HbA1c-derived diabetes status
- Diabetes
- Label vs HbA1c discordant
- No
- Tier 1 complete
- Yes
- Family history relationship
- -
- Living donor
- No
- Cause of death
- Cerebrovascular/stroke
- Medication
- Oral medications
HLA typing
| Locus | Allele 1 | Allele 2 | Method |
|---|---|---|---|
| A | 24 | 68 | OPO |
| B | 42 | 44 | OPO |
| C | 04 | 17 | OPO |
| Bw4 | 1 | — | OPO |
| Bw6 | 1 | — | OPO |
| DR | 13 | 15 | OPO |
| DR51 | 1 | — | OPO |
| DR52 | 1 | — | OPO |
| DR53 | 0 | — | OPO |
| DQ | 6 | 6 | OPO |
Supplementary
IIDP
IIDP:SAMN08773855
- Pancreas tissue available
- No
- Other tissues
- —
External resources
IIDP:SAMN08773855
Attribution
Supported by National Institutes of Health (NIH) grants U24 DK138515, U24 DK138512
Supplemental funds from the NIH Office of Data Science Strategies
Supplemental funds from the NIH Office of Data Science Strategies
